Press release
Diabetic Retinopathy Market Size Forecast 2019 with Bayer, Novartis, Regeneron Pharmaceuticals, Inc., Genentech, Allergan
The Diabetic Retinopathy Market set to expected witness growth of over 6.5% CAGR from 2019 to 2024.Rising number of baby boomers globally coupled with growing incidences of diabetes will act as primary drivers for diabetic retinopathy market. Elderly people are prone to suffer from chronic diseases such as diabetes as well as age related macular degeneration (AMD). According to National Eye Institute (NEI) estimates, nearly 5.4 million people in the U.S. will suffer from age related macular degeneration (AMD) by 2050.
Growing adoption of sedentary lifestyle accompanied by unhealthy diet has escalated number of people suffering from obesity and increased incidence of diabetes. Further, factors such as prolonged undiagnosed diabetes, non-compliance to treatment, and uncontrolled blood pressure and glucose levels lead to occurrence of diabetic retinopathy. Rising incidences of vision loss due to diabetes will propel industry growth.
Presence of associations such as American Diabetes Association working towards creating awareness about diabetic retinopathy and related blindness will fuel market growth. Several efforts undertaken by domestic government to reduce disease prevalence by conducting programs such as diabetic eye screening (DES) program and various awareness campaigns will drive market growth. Rising healthcare expenditure, increasing demand for innovative treatment, technological advancements and growing R&D efforts for developing more efficient and affordable treatment for disease will drive diabetic retinopathy market over the forecast timeframe.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/486
Non-proliferative diabetic retinopathy segment dominated global diabetic retinopathy market in 2016 and is estimated to follow similar trend over the forecast period. Increasing number of people suffering from diabetic retinopathy coupled with growing disease awareness will continue to drive non-proliferative diabetic retinopathy market.
Technological advancements including laser treatment, injections pertaining to diabetic retinopathy treatment coupled with rising number of severe diabetic retinopathy cases will favour growth of proliferative diabetic retinopathy market over the coming years. Factors such as non-compliance to treatment, undiagnosed diabetes as well as less awareness about eye-check-ups and vision loss due to diabetes accelerates incidences of proliferative diabetic retinopathy.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
Bayer
Novartis
Regeneron Pharmaceuticals, Inc.
Genentech
Allergan
Anti-VEGH segment accounted for largest market share in 2016. Multifactorial benefits such as fewer chances of haemorrhages associated with anti-VEGF injection, better results delivered by anti-VEGF therapy as compared to other treatment methods coupled with technological advancement in Anti-VEGF therapy will drive Anti-VEGH diabetic retinopathy market over the forecast timeframe.
Browse Full Report Details @ https://www.gminsights.com/industry-analysis/diabetic-retinopathy-market-report
Intraocular steroid injection segment will witness considerable growth during the forecast timeframe owing to easy accessibility in clinics, growing demand for non-invasive treatment and less time required for procedure. Factors such as cataract formation and rise in eye pressure due to intraocular steroid injection may hinder market growth.
U.S. dominated North America diabetic retinopathy market in 2016 due to growing incidences of irreversible blindness due to diabetic retinopathy and rising adoption of unhealthy diet and sedentary lifestyle. Presence of several market players and associations such as American Diabetes Association working towards reducing disease prevalence in the country will fuel market growth. Increasing incidences of diabetes among elderly as well as youth population will further boost industry growth.
Rising number of people suffering from diabetes coupled with high technological adoption will drive Germany diabetic retinopathy market over the forecast period. Increasing healthcare expenditure along with growing research towards developing effective treatment for diabetes associated blindness will fuel market growth.
Growing geriatric population base and rising incidences of diabetes will act as major driver for Chinese diabetic retinopathy market. Numerous efforts undertaken by public and private players to increase awareness about diabetic retinopathy as well as reduce disease occurrence in the country will favour market growth. However, dearth of skilled ophthalmologists in the country will hinder industry growth over the coming years.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/486
Industry players are focusing towards developing effective solution for treating diabetes retinopathy. For instance, Lucentis developed by Genentech in April 2017 received U.S. FDA approval for use in treating all forms of diabetes retinopathy. Diabetic retinopathy is largely observed among elderly people. Hence increasing number of baby boomers will act as primary driver for the market. Technological advancements in laser treatment, intraocular steroid injections along with growing research and development activities towards developing innovative solutions for treating vision impairment associated with diabetes will drive diabetic retinopathy market during the forecast timeframe.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://solutionrocket.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Retinopathy Market Size Forecast 2019 with Bayer, Novartis, Regeneron Pharmaceuticals, Inc., Genentech, Allergan here
News-ID: 1539214 • Views: …
More Releases from Global Market Insights,Inc.

Guidewires Market Revenue Forecast 2026 By Regional Players Abbott Laboratories, …
Guidewires Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
The guidewires market is slated to witness considerable revenue growth over the coming years, undeniably attributing to the rising preference for minimally invasive surgeries across the globe. According to…

Scanning Electron Microscope Market Forecast 2027 | Carl Zeiss, Thermo Fischer S …
Scanning Electron Microscope Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
Technological advancements in developing microscopes with high integration and resolution power have spurred the demand for scanning electron microscopes (SEM). These microscopes are primarily utilized for quality…
New growth opportunities for textile market players, which will directly influen …
Muconic Acid Market share is forecast to surpass USD 60 million by 2024; according to a new research report by Global Market Insights, Inc. Muconic acid market will be primarily driven by textile and plastics industry growth in the near future. Increasing per capita income of consumers, especially in Latin America and Asia Pacific, is directly increasing their expenditure budget, which implies improved living standards. This presents new growth opportunities…

Glutathione Market overview by 2025| Kyowa Hakko Bio Co. Ltd.,, Shandong Jinchen …
Glutathione market has been expanding due to the oxidative stress reducing properties of glutathione that have found widespread application in the context of rising stress levels. Glutathione supplements in diet have witnessed demand due to their nutritional benefits and accredited for boosting glutathione industry size.
According to the reliable reports, by 2020, chronic diseases will account for almost three-quarters of all deaths globally. Out of these 71% of deaths will…
More Releases for Diabetic
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Leading Element Driving Change in the Diabetic Footwear Market in 2025: Rising D …
Which drivers are expected to have the greatest impact on the over the diabetic footwear market's growth?
The surge in people with diabetes will spur the expansion of the diabetic footwear market in the future. Diabetes, characterised by high blood sugar levels, is a long-term health issue. Diabetic footwear can prevent severe foot-related issues caused by diabetes and offer several advantages such as enhanced blood flow, ample space for the toes,…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…